Current Activities and Projects include:- Consulting on product commercialization, sales & marketing issues, alliance management and all business development activities on a global basis- Expert on the anti-infectives space including hospital antibiotics- Develop product assessments and forecast expectations along with effective launch strategies- CEO of a nutraceutical ingredients company ( active in funding raising)- QORM LLC, a consulting company providing Quality/QA, Operations, Regulatory and Management strategy assessment Core Competencies:• Leadership: Globalized a hospital injectable antibiotic using a direct USA product launch and a series of international partnerships. Provided the strategy and vision for management of the partnerships through internal and external teams aligned around common goals• Business Results: Built numerous commercially successful business lines in the pharmaceutical industry that have delivered approximately $950 M in cumulative revenue with continuous profit growth from 1993 to 2013• Product Results: Generated international sales of a hospital injectable antibiotic with cumulative revenue of $400 M for partners with a high gross royalty. Launched Melatonin into the nutraceutical industry capturing nearly 100% of the market over a period of 3 years. Bulk Melatonin sales of $50 M resulted in retail sales of $350 M • International Alliance Management: Led the creation of the alliance management function at a major biotechnology company. Created cross-functional internal teams and aligned these teams across 7 major pharmaceutical and biotechnology partners. Contributed to international launches in China, Japan and Europe• Business Development: Extensive business development experience with a focus on out-licensing activities. Total deal value of $225 M coming from upfront/milestone payments and supply agreements

Retired December 2013

• Re-engineered the business strategy at Genzyme to deprioritize bulk generic drug sales and to concentrate on specialty chemicals and manufacturing of approved drugs for pharmaceutical companies under contract with Genzyme* Commercialized low molecular weight hyaluronic acid into the eye surgery market* Built the phospholipids, liquid crystals and bulk research chemicals business units

* Developed all new products for the company* Created the Pharmacist Choice line of nutritional supplments* Brought prescription products into the P. Leiner OTC drug line

* Managed all oil soluble vitamin products such as: Vitamin E, Vitamin A, and Beta-Carotene, which generated $30 M in sales* Developed marketing plans, managed internal projects i.e.: Beta-Carotene 5-year plan, which included plant capacity issues, value added product forms, sales force focus and promotional strategy

* Promoted Upjohn's ethical and OTC products to physicians, hospitals and drugstores * Products included: Motrin, Clindamycin, Solu-medrol, Unicap Vitamins and Cheracol D